GlassScriptPhysician profile
Lillian J Choi
NPI 1831350453
$1,331.00
in general payments reported to CMS, 2019-2025
12 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $46.14 · 2021: $111 · 2022: $53.88 · 2023: $166 · 2024: $401 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $369.53 | 2022-2025 | |
| Abbvie INC. | $262.66 | 2019-2023 | Rinvoq, Skyrizi |
| Qol Medical, LLC | $145.68 | 2019-2025 | Sucraid, Sucraid |
| Shire North American Group INC | $134.99 | 2019 | |
| Alcresta Therapeutics, INC. | $116.35 | 2024 | Relizorb |
| Travere Therapeutics, INC. | $69.76 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $67.23 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $58.91 | 2023 | Dupixent |
| Nestle Healthcare Nutrition INC. | $41.89 | 2021-2022 | |
| Sandoz INC. | $24.87 | 2025 | Hyrimoz |
| Alexion Pharmaceuticals, INC. | $19.81 | 2019 | |
| Celltrion USA INC. | $19.32 | 2025 | Vegzelma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.